<html>
  <head>
    <meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy | Lum&#39;s Notes</title>
<link rel="shortcut icon" href="https://lumluminous.github.io/blog/favicon.ico?v=1658559265011">
<link href="https://cdn.jsdelivr.net/npm/remixicon@2.3.0/fonts/remixicon.css" rel="stylesheet">
<link rel="stylesheet" href="https://lumluminous.github.io/blog/styles/main.css">
<link rel="alternate" type="application/atom+xml" title="IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy | Lum&#39;s Notes - Atom Feed" href="https://lumluminous.github.io/blog/atom.xml">
<link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Droid+Serif:400,700">



    <meta name="description" content="Biomaterials,2022.https://doi.org/10.1016/j.biomaterials.2021.121341.

Abstract
作者开发了一种IL-12 纳米激动剂结合工程化的CAR T 细胞的生物杂交体(I..." />
    <meta name="keywords" content="Lab,Study" />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.10.0/katex.min.css">
    <script src="//cdn.jsdelivr.net/gh/highlightjs/cdn-release@11.5.1/build/highlight.min.js"></script>
  </head>
  <body>
    <div class="main">
      <div class="main-content">
        <div class="site-header">
  <a href="https://lumluminous.github.io/blog">
  <img class="avatar" src="https://lumluminous.github.io/blog/images/avatar.png?v=1658559265011" alt="">
  </a>
  <h1 class="site-title">
    Lum&#39;s Notes
  </h1>
  <p class="site-description">
    
  </p>
  <div class="menu-container">
    
      
        <a href="/" class="menu">
          首页
        </a>
      
    
      
        <a href="/archives" class="menu">
          归档
        </a>
      
    
      
        <a href="/tags" class="menu">
          标签
        </a>
      
    
      
        <a href="/post/about" class="menu">
          关于
        </a>
      
    
  </div>
  <div class="social-container">
    
      
    
      
    
      
    
      
    
      
    
  </div>
</div>

        <div class="post-detail">
          <article class="post">
            <h2 class="post-title">
              IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy
            </h2>
            <div class="post-info">
              <span>
                2022-07-21
              </span>
              <span>
                3 min read
              </span>
              
                <a href="https://lumluminous.github.io/blog/tag/84jnI76mk/" class="post-tag">
                  # Lab
                </a>
              
                <a href="https://lumluminous.github.io/blog/tag/gHqGWJV4-/" class="post-tag">
                  # Study
                </a>
              
            </div>
            
            <div class="post-content-wrapper">
              <div class="post-content" v-pre>
                <p>Biomaterials,2022.https://doi.org/10.1016/j.biomaterials.2021.121341.</p>
<figure data-type="image" tabindex="1"><img src="https://raw.githubusercontent.com/lumluminous/Picbed_Picgo/main/20220721192407.png" alt="" loading="lazy"></figure>
<h3 id="abstract">Abstract</h3>
<p>作者开发了一种IL-12 纳米激动剂结合工程化的CAR T 细胞的生物杂交体(INS-CART)，其中，IL-12纳米佐剂能够有效地结合CART 细胞，且IL-12能够在肿瘤抗原的刺激响应下有效地释放，释放出的IL-12能够进一步促进CCL5、CCL2及CXCL10 的分泌，进一步在肿瘤微环境中招募CD8+的CAR T 细胞。作者发现，这种策略可以显著地提高CAR T 细胞对实体肿瘤的抗肿瘤能力，并最大限度地减少了副作用。这种INS-CAR T 生物杂交体，可以成为一种高效、安全的抗肿瘤免疫治疗的良好工具。</p>
<h4 id="research-topic"><strong>Research Topic</strong></h4>
<p>具有免疫应答的IL-12纳米粒子结合工程化CAR T 细胞 (INS-CAR T)及增强实体瘤的免疫治疗</p>
<h4 id="background"><strong>Background</strong></h4>
<p>（1）物理屏障和促癌因子是限制CAR T疗法的主要因素；</p>
<p>（2）白细胞介素IL-12 是能够引发免疫反应的关键佐剂；</p>
<p>（3）然而，临床研究中IL-12的全身给药会引发促炎反应和毒性，同时体内分泌的IL-12水平也难以实现准确控制，难以直接利用白细胞介素IL-12进行肿瘤治疗；</p>
<p>（4）需要设计一种可控的策略将IL-12高效递送到肿瘤微环境中。</p>
<h4 id="methodology"><strong>Methodology</strong></h4>
<h5 id="制备">制备：</h5>
<p>设计了负载有IL-12 (INS) 激动剂的HSA 纳米颗粒</p>
<h5 id="抗肿瘤能力">抗肿瘤能力：</h5>
<ol>
<li>荧光定量分析：CAR T 细胞表面的氧化还原硫醇破坏 INS纳米粒子与CAR T细胞的结合从而释放 IL-12</li>
<li>SEM表征：CAR T 细胞能够通过肿瘤抗原刺激响应来释放INS 纳米粒子</li>
<li>Raji肿瘤细胞3D球体、流式、ELISA：研究肿瘤浸润和细胞毒性</li>
<li>Raji荷瘤NOD/SCID 小鼠：荷瘤小鼠在肿瘤接种8天后分别静脉注射游离CAR T细胞、IL-12 + CAR T细胞和INS-CAR T细胞。使用体内生物发光成像分析监测每只小鼠的肿瘤生长情况。</li>
</ol>
<h4 id="outcomes-and-value"><strong>Outcomes and Value</strong></h4>
<p>作者研究了一种IL-12纳米离子结合CAR T细胞 (INS-CAR T) 的生物杂交体工程策略。INS-CAR T生物杂化体作为一种新型CAR T细胞治疗策略，具有出色的抗肿瘤功效和生物安全性。通过使用负载IL-12的纳米粒子和肿瘤抗原响应性，INS-CAR T 生物杂交体可以诱导强大且安全的抗肿瘤免疫，包括抗肿瘤因子的高表达、选择性增殖、有效募集和CAR T细胞的深度渗透。</p>
<h4 id="未来课题">未来课题</h4>
<p>新材料，纳米佐剂结合CAR-T的细胞疗法</p>

              </div>
              <div class="toc-container">
                <ul class="markdownIt-TOC">
<li>
<ul>
<li>
<ul>
<li><a href="#abstract">Abstract</a>
<ul>
<li><a href="#research-topic"><strong>Research Topic</strong></a></li>
<li><a href="#background"><strong>Background</strong></a></li>
<li><a href="#methodology"><strong>Methodology</strong></a>
<ul>
<li><a href="#%E5%88%B6%E5%A4%87">制备：</a></li>
<li><a href="#%E6%8A%97%E8%82%BF%E7%98%A4%E8%83%BD%E5%8A%9B">抗肿瘤能力：</a></li>
</ul>
</li>
<li><a href="#outcomes-and-value"><strong>Outcomes and Value</strong></a></li>
<li><a href="#%E6%9C%AA%E6%9D%A5%E8%AF%BE%E9%A2%98">未来课题</a></li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>

              </div>
            </div>
          </article>
        </div>

        
          <div class="next-post">
            <div class="next">下一篇</div>
            <a href="https://lumluminous.github.io/blog/post/batf-and-irf4-cooperate-to-counter-exhaustion-in-tumor-infiltrating-car-t-cells/">
              <h3 class="post-title">
                BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells
              </h3>
            </a>
          </div>
        

        
          
            <link rel="stylesheet" href="https://unpkg.com/gitalk/dist/gitalk.css">
<script src="https://unpkg.com/gitalk/dist/gitalk.min.js"></script>

<div id="gitalk-container"></div>

<script>

  var gitalk = new Gitalk({
    clientID: '',
    clientSecret: '',
    repo: '',
    owner: '',
    admin: [''],
    id: (location.pathname).substring(0, 49),      // Ensure uniqueness and length less than 50
    distractionFreeMode: false  // Facebook-like distraction free mode
  })

  gitalk.render('gitalk-container')

</script>

          

          
        

        <div class="site-footer">
  Powered by <a href="https://github.com/getgridea/gridea" target="_blank">Gridea</a>
  <a class="rss" href="https://lumluminous.github.io/blog/atom.xml" target="_blank">
    <i class="ri-rss-line"></i> RSS
  </a>
</div>

      </div>
    </div>

    <script>
      hljs.initHighlightingOnLoad()

      let mainNavLinks = document.querySelectorAll(".markdownIt-TOC a");

      // This should probably be throttled.
      // Especially because it triggers during smooth scrolling.
      // https://lodash.com/docs/4.17.10#throttle
      // You could do like...
      // window.addEventListener("scroll", () => {
      //    _.throttle(doThatStuff, 100);
      // });
      // Only not doing it here to keep this Pen dependency-free.

      window.addEventListener("scroll", event => {
        let fromTop = window.scrollY;

        mainNavLinks.forEach((link, index) => {
          let section = document.getElementById(decodeURI(link.hash).substring(1));
          let nextSection = null
          if (mainNavLinks[index + 1]) {
            nextSection = document.getElementById(decodeURI(mainNavLinks[index + 1].hash).substring(1));
          }
          if (section.offsetTop <= fromTop) {
            if (nextSection) {
              if (nextSection.offsetTop > fromTop) {
                link.classList.add("current");
              } else {
                link.classList.remove("current");    
              }
            } else {
              link.classList.add("current");
            }
          } else {
            link.classList.remove("current");
          }
        });
      });

    </script>
  </body>
</html>
